- Home
- Innovation
Innovation
Johnson & Johnson earns a spot on Fortune‘s 2021 Change the World list.
The company is honored to be recognized for its part in helping battle the COVID-19 pandemic.
The next frontier of prostate cancer care
Certain gene mutations can dramatically increase the risk of developing aggressive prostate cancer. That’s why Johnson & Johnson is researching a new way to fight the disease—one that involves blocking cancer cells from repairing their own damaged DNA.
Curing cancer from within: The promise of cell therapy
Harnessing the immune system to target cancer is the goal of a groundbreaking area of oncology research called cell therapy. And Johnson & Johnson is hard at work in the cutting-edge field, aiming to deliver potential new treatment options to people around the world.
How your own DNA could someday save your vision
Imagine living with a genetic disease that could cause blindness in your 40s—and your doctor tells you there are no treatment options. It’s for patients like these that Johnson & Johnson is harnessing cutting-edge technology in the hope of finding real solutions.
Johnson & Johnson award winner David Julius, Ph.D., receives a 2021 Nobel Prize
The company honored him in 2013 with a Dr. Paul Janssen Award for Biomedical Research; now he’s a Nobel Laureate. Learn about the transformational research that’s led to these well-deserved scientific accolades.
Two pioneering RNA scientists win the 2021 Dr. Paul Janssen Award for biomedical research
Learn how their revolutionary work has not only had a crucial impact on the COVID-19 pandemic but is also paving the way for potential future vaccines and treatments.
How drones are being used to deliver lifesaving HIV drugs to remote areas of the world
Normally, in this part of Uganda, medication is delivered by boat—a slow, difficult process. But now a new Johnson & Johnson-supported program is using drones that can serve 20 landing sites across five islands, reaching more than 3,700 people in a single day.
3 cutting-edge eye lenses designed to help improve how you see
Multifocal contacts based on your pupil size. Intraocular lenses that adapt to our digital world. These are just some of the new Johnson & Johnson advances poised to change the future of vision care.
How Johnson & Johnson has pioneered in the battle against HIV/AIDS
For World AIDS Day, we look at the groundbreaking strides the company has made—and continues to make—toward a world without the disease.
What to know about HDFN, a serious blood disorder in babies, including a possible new treatment
Severe cases of hemolytic disease of the fetus and newborn can be deadly in infants. That’s why Johnson & Johnson is passionate about investigating a promising option for treating the disorder.